EUVIMEDOpdag EUVIMED
Open access

Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

Xue Li, Dengfeng Zhang, Pengfei Guo, Shaowei Ma, Shaolin Gao, Shujun Li, Yadong Yuan

Aging · 2024

DOI: 10.18632/aging.205705 ↗

At a glance

Journal article in Aging, 2024. Written by Xue Li and 6 co-authors. Institution: Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China. Major MEDLINE topics: Tumor Microenvironment, Adenocarcinoma of Lung, Lung Neoplasms, Immunotherapy. 25 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

BACKGROUND: Immunogenic cell death (ICD) is a regulated form of cell death that triggers an adaptive immune response. The objective of this study was to investigate the correlation between ICD-related genes (ICDGs) and the prognosis and the immune microenvironment of patients with lung adenocarcinoma (LUAD). METHODS: ICD-associated molecular subtypes were identified through consensus clustering. Subsequently, a prognostic risk model comprising 5 ICDGs was constructed using Lasso-Cox regression in the TCGA training cohort and further tested in the GEO cohort. Enriched pathways among the subtypes were analyzed using GO, KEGG, and GSVA. Furthermore, the immune microenvironment was assessed using ESTIMATE, CIBERSORT, and ssGSEA analyses. RESULTS: Consensus clustering divided LUAD patients into three ICDG subtypes with significant differences in prognosis and the immune microenvironment. A prognostic risk model was constructed based on 5 ICDGs and it was used to classify the patients into two risk groups; the high-risk group had poorer prognosis and an immunosuppressive microenvironment characterized by low immune score, low immune status, high abundance of immunosuppressive cells, and high expression of tumor purity. Cox regression, ROC curve analysis, and a nomogram indicated that the risk model was an independent prognostic factor. The five hub genes were verified by TCGA database, cell sublocalization immunofluorescence analysis, IHC images and qRT-PCR, which were consistent with bioinformatics analysis. CONCLUSIONS: The molecular subtypes and a risk model based on ICDGs proposed in our study are both promising prognostic classifications in LUAD, which may provide novel insights for developing accurate targeted cancer therapies.

Subjects

MeSH terms (MEDLINE)

Tumor MicroenvironmentAdenocarcinoma of LungLung NeoplasmsImmunotherapyImmunogenic Cell DeathHumansPrognosisGene Expression Regulation, NeoplasticBiomarkers, TumorGene Expression ProfilingMaleTranscriptomeFemale

Author keywords

immunogenic cell deathimmunotherapylung adenocarcinomaprognosistumor microenvironment

Substances

Biomarkers, Tumor

Authors and institutions

  • Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
  • Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
  • Department of Gastrointestinal Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Cite

APA

Li, X., Zhang, D., Guo, P., Ma, S., Gao, S., Li, S., & Yuan, Y. (2024). Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.205705

Vancouver

Li X, Zhang D, Guo P, Ma S, Gao S, Li S, et al. Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. Aging. 2024. doi:10.18632/aging.205705

BibTeX
@article{Li2024,
  author = {Li, Xue and Zhang, Dengfeng and Guo, Pengfei and Ma, Shaowei and Gao, Shaolin and Li, Shujun and Yuan, Yadong},
  title = {Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205705}
}
Start for free →